Comprehensive bioinformatic analysis reveals TRPM4 as a biomarker for pan-cancer progression and macrophage infiltration
Our research highlights TRPM4 as a promising biomarker and a therapeutic target for cancer treatment. Future investigations should focus on elucidating the mechanistic role of TRPM4 in modulating immune response and tumor progression, potentially paving the way for innovative therapeutic strategies in oncology.
Authors
- Ling Gu (ORCID: https://orcid.org/0000-0002-3368-4053)
- Ruikun Hu (ORCID: https://orcid.org/0000-0001-8148-6134)
- Xingsong Zhang
- PanFeng Feng
- Mingyang Hong
- Xu Huang
Institutions
- Nantong University (CN)
- Nantong Maternity and Child Health Hospital (CN)
- Affiliated Hospital of Nantong University (CN)
- Nantong Tumor Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1007/s12672-026-04806-7
- Primary Topic
- Ion Channels and Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00